• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Neurology

ECTRIMS 2019 DAILY REPORT – SATURDAY EDITION

September 14, 2019  

Ofatumumab – new data
Biotin – disappointing results
Natalizumab – 10-year data
Dimethyl fumarate – 10-year results
Declining effect of treatment
Stopping treatment: 2 studies
BTK inhibition
Clinical Tip of the day Read More

TOPICS: MS

ECTRIMS 2019 DAILY REPORT – FRIDAY EDITION

September 13, 2019  

Siponimod in SPMS
Alemtuzumab – 9-year results
Ocrelizumab in PPMS – extension data
Starting and switching DMTs
RIS – Predictors of CIS/MS
Do real-world people enter real-world studies?
Clinical Tip of the day Read More

TOPICS: MS

ECTRIMS Poster Picks – Friday, September 13

September 13, 2019  

Friday, September 13, 2019 – Today’s poster session runs from 12:15-2:15 pm
Here are Steven’s Top poster topics at ECTRIMS for Friday, September 13, 2019. Read More

ECTRIMS 2019 DAILY REPORT – THURSDAY EDITION

September 12, 2019  

Phase III trials in NMOSD
Cladribine and time to SPMS
Hypogammaglobulinemia
Cannabis and cognition
Concussion and MS
Clinical Tip of the day Read More

TOPICS: MS

ECTRIMS Poster Picks – Thursday, September 12

September 12, 2019  

Thursday, September 12, 2019 – Today’s poster session runs from 5:15-7:15 pm
Here are Steven’s Top poster topics at ECTRIMS for Thursday, September 12. Read More

Previous
45
46
47
48
49
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions